Status:

COMPLETED

Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Dementia

Alzheimer's Disease

Eligibility:

All Genders

60-100 years

Phase:

NA

Brief Summary

Alzheimer's disease and related disorders (AD2) are characterised by cognitive changes and Behavioural and Psychological Symptoms of Dementia (BPSD). According to the French National Authority for Hea...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Participants will have to present a NPI score of 9 or more on at least one of the following items : apathy, agitation, anxiety, depression, aberrant motor behavior.
  • The behavioural disorders do not prevent the participation in a session.
  • For participants able to give consent:
  • Written informed consent to participate in the study
  • Informed consent of the participant in the presence of his/her curator for participant under curatorship.
  • For participants who are not able to receive information and to give consent:
  • Written informed consent of the legal representative (tutor) for participants under tutelage.
  • Signature of a relative (family member and/or trusted person) of the participant
  • The participant has to be affiliated to a social security scheme.
  • Exclusion Criteria :
  • Unstable pathology whose nature may interfere with the assessment variables:
  • Neurological disorder of infectious origin
  • Psychiatric disorder
  • Substance abuse
  • Severe uncompensated sensory deficit
  • History of epilepsy
  • Pacemaker or severe and/or uncontrolled heart disease (at the discretion of the investigator)
  • Visual hallucinations
  • Burns and sores on the upper face or scalp
  • Unable to express their consent, without a trusted person (family or close friend) and not legally protected

Exclusion

    Key Trial Info

    Start Date :

    December 2 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 4 2024

    Estimated Enrollment :

    56 Patients enrolled

    Trial Details

    Trial ID

    NCT04769024

    Start Date

    December 2 2022

    End Date

    March 4 2024

    Last Update

    December 3 2024

    Active Locations (6)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (6 locations)

    1

    EHPAD du Centre Hospitalier du Pays de Craponne Sur Arzon

    Craponne-sur-Arzon, France, 43500

    2

    EHPAD du Centre Hospitalier Emile Roux

    Le Puy-en-Velay, France, 43000

    3

    EHPAD Saint-Joseph

    Le Puy-en-Velay, France, 43000

    4

    EHPAD Maison Saint-François d'Assise Lyon

    Lyon, France, 69001